Shortwave Life Sciences Plc
@ShortwavePLC
Biopharmaceutical company developing novel drug combinations & delivery method to treat patients from mental health disorders. Listed on AQSE: #PSY
Investor Newsletter: Stay informed with the latest updates and announcements from Shortwave Life Sciences. 📩 Subscribe by visiting the contact page and signing up at the bottom: shortwavelifesciences.com/contact/ #PSY
Eating disorders remain among the most fatal of all psychiatric conditions. At Shortwave, our pipeline aims to address the biological roots behind this global challenge. 🔗 buff.ly/mt0IeKz #PSY
Tune into the latest #ResearchTalks Podcast with @StockBoxMedia @MarkEJFairbairn, @Alan__Green @Brand_UK & writer @danielflynn92. 🎧 LISTEN HERE:youtu.be/VYXdBSMy_Jc ➡️ @URUMetals (LSE: URU) ➡️ @CriticalMinRes (LSE: CMRS) ➡️ One Health Group (LSE: OHGR) ➡️…
Our proprietary psilocybin + β-carboline formula for anorexia offers better bioavailability, lower dose, and extended efficacy, delivered via mucoadhesive film. Partnered exclusively with Sheba Medical Center. #PSY
Innovation beyond the lab: Shortwave has recently appointed Archax as its digital asset treasury partner, aligning with the long-term vision for secure, efficient capital management. Details 🔗londonstockexchange.com/news-article/m… #PSY
Anorexia Nervosa - the most fatal mental health condition. No FDA-approved treatment exists. Shortwave aims to change that. #PSY
Every element of our strategy from pipeline to partnerships, supports one goal: advancing treatment innovation for life-threatening psychiatric and eating disorders. Our mission remains clear: bridge early discovery with real-world impact. Learn more: shortwavelifesciences.com
Pharma Model is Broken. ⏳ 10–15 years to approval. 💸 Less than 10% of drug candidates reach approval, with most failing in costly late-stage trials. Patients wait and suffer. Shortwave is rewiring the model with speed, efficiency and sustainable funding. #PSY
@ShortwavePLC (AQSE: #PSY) announce the publication of its patent application for its mucoadhesive composition and method for administration of pharmaceutically effective agents, Buccal film formation. share-talk.com/shortwave-life…
🔔Shortwave Life Sciences is pleased to announce the publication of its patent application for its mucoadhesive composition and method for administration of pharmaceutically effective agents, Buccal film formation. Read more here: aquis.eu/stock-exchange… #PSY
Our new Strategic Plan outlines how Shortwave will bridge early-stage science and scalable therapeutics in psychiatric health. Read how we’re positioning for long-term growth via recent news: shortwavelifesciences.com/investor-centr… #PSY
Shortwave Life Sciences announced its Annual General Meeting for 28 Nov 2025, where shareholders will vote on a significant capital reorganisation & the formal adoption of a Digital Asset Treasury Policy. Read more: aquis.eu/stock-exchange… #PSY
Why now? Mental health crisis rising. Regulators opening doors to new therapies. Digital assets gaining institutional adoption. Shortwave stands at the inflection point — biotech + blockchain, the next frontier. #PSY
Shortwave uniquely positioned at the convergence of two high-growth markets. 🧠 $180B CNS disorders by 2030 💰 Digital Assets $4T market cap +245% last two years Learn more: buff.ly/XMhoezN #PSY
Shortwave Life Sciences is pleased to present its results for the financial year ended 30 April 2025. The Group's mission is to pioneer breakthrough therapies that transform the landscape of mental health care. 🩺 Read here: aquis.eu/stock-exchange… #PSY
Leveraging digital asset liquidity to accelerate life-changing therapies. 🌐 Medicine is shifting - focus shifts to unmet mental health needs. Capital is too, Shortwave unites biotech innovation with digital finance. Read more: buff.ly/EG5de3j #PSY
Shortwave Oct 2025 Corporate Presentation is now available. 📝 ‘Rewiring Biotech: Clinical Breakthroughs Powered by Digital Treasury’ Read the full presentation here: shortwavelifesciences.com/investor-centr… #PSY
Shortwave is preparing to share new milestones, partnerships, and updates. Stay tuned. 🔗 shortwavelifesciences.com/investor-centre #PSY
A major new study launched earlier in the year recruiting 10,000 people with eating disorders to uncover genetic & environmental causes. The research is essential to unlock new therapeutic targets. 🔗 beateatingdisorders.org.uk/news/beat-news… #EDResearch
United States Trends
- 1. James Comey 19.9K posts
- 2. Thanksgiving 152K posts
- 3. Comey and James 12.8K posts
- 4. Jimmy Cliff 27.6K posts
- 5. #IDontWantToOverreactBUT 1,424 posts
- 6. #WooSoxWishList 4,566 posts
- 7. #NutramentHolidayPromotion N/A
- 8. Pentagon 9,879 posts
- 9. #MondayMotivation 14.2K posts
- 10. The Department of War 10.7K posts
- 11. DISMISSED 22.2K posts
- 12. DOGE 239K posts
- 13. #GEAT_NEWS 1,460 posts
- 14. Sen. Mark Kelly 15.7K posts
- 15. Monad 179K posts
- 16. TOP CALL 5,112 posts
- 17. Victory Monday 5,073 posts
- 18. Feast Week 2,335 posts
- 19. Hal Steinbrenner N/A
- 20. Zach Bryan N/A
Something went wrong.
Something went wrong.